Related Experiment Video

Updated: Jun 22, 2026

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study

A Galor1, C L Karp, S Chhabra

  • 1Bascom Palmer Eye Institute, 900 NW 17 Street, Miami, FL 33136, USA.

The British Journal of Ophthalmology
|June 5, 2009
PubMed

Insights

Two doses of interferon alpha2b eye-drops showed similar effectiveness for conjunctival intraepithelial neoplasia (CIN). Both 1 million and 3 million IU/ml doses were well-tolerated, with no significant differences in treatment outcomes for ocular surface squamous neoplasia (OSSN).

Area of Science:

  • Ophthalmology
  • Oncology
  • Pharmacology

Background:

  • Ocular surface squamous neoplasia (OSSN) is a premalignant and malignant condition affecting the eye.
  • Interferon alpha2b (IFNalpha2b) eye-drops are used to treat OSSN.
  • Comparing different dosages of IFNalpha2b is crucial for optimizing treatment.

Purpose of the Study:

  • To compare the effectiveness and side-effect profile of two doses of topical interferon alpha2b (IFNalpha2b) eye-drops.
  • Investigate the efficacy of 1 million IU/ml versus 3 million IU/ml IFNalpha2b in treating ocular surface squamous neoplasia (OSSN).

Main Methods:

  • Retrospective case series analysis of 35 eyes diagnosed with OSSN between 1996 and 2007.
  • Patients with conjunctival intraepithelial neoplasia (CIN) received either 1 million IU/ml or 3 million IU/ml topical IFN-alpha2b.
  • Two patients with squamous cell carcinoma (SCC) were also treated with topical interferon.

Main Results:

  • Topical therapy eliminated CIN in 81% of eyes (1 million IU/ml group) and 92% (3 million IU/ml group), with no statistically significant difference (p=0.41).
  • Median time to OSSN resolution was 2.8 months (1 million IU/ml) vs. 1.9 months (3 million IU/ml), also not significantly different (p=0.55).
  • Neither SCC case responded to interferon therapy; topical treatment was generally well-tolerated with three recurrences observed after a median 24-month follow-up.

Conclusions:

  • No significant differences were observed between 1 million IU/ml and 3 million IU/ml topical IFNalpha2b for the treatment of conjunctival intraepithelial neoplasia (CIN).
  • Both dosages were well-tolerated, suggesting comparable safety profiles.
  • Further research may be needed to evaluate efficacy in squamous cell carcinoma (SCC).

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...